Identification and Characterization of FTY720 for the Treatment of Human African Trypanosomiasis.

about

Screening a Natural Product-Based Library against Kinetoplastid Parasites.Novel lead compounds in pre-clinical development against African sleeping sickness

P2860

Q42796077-268ABD09-E10E-4344-BC66-D915FDD97390 Q58842335-C960D928-B531-497F-A775-8397BEFCDDB5

P2860

Identification and Characterization of FTY720 for the Treatment of Human African Trypanosomiasis.

Item

http://www.wikidata.org/entity/Q35868574

description

2015 nî lūn-bûn

@nan

2015年の論文

@ja

2015年論文

@yue

2015年論文

@zh-hant

2015年論文

@zh-hk

2015年論文

@zh-mo

2015年論文

@zh-tw

2015年论文

@wuu

2015年论文

@zh

2015年论文

@zh-cn

name

Identification and Characteriz ...... Human African Trypanosomiasis.

@ast

Identification and Characteriz ...... Human African Trypanosomiasis.

@en

type

Item

label

Identification and Characteriz ...... Human African Trypanosomiasis.

@ast

Identification and Characteriz ...... Human African Trypanosomiasis.

@en

prefLabel

Identification and Characteriz ...... Human African Trypanosomiasis.

@ast

Identification and Characteriz ...... Human African Trypanosomiasis.

@en

P1476

Identification and Characteriz ...... Human African Trypanosomiasis.

@en

P2093

Amy J Jones

http://www.w3.org/2001/XMLSchema#string

P2860

SCYX-7158, an orally-active benzoxaborole for the treatment of stage 2 human African trypanosomiasis

Fexinidazole--a new oral nitroimidazole drug candidate entering clinical development for the treatment of sleeping sickness

Molecular cloning and functional characterization of a novel mammalian sphingosine kinase type 2 isoform

Epidemiology of human African trypanosomiasis

Identification of compounds with anti-proliferative activity against Trypanosoma brucei brucei strain 427 by a whole cell viability based HTS campaign

Can the pharmaceutical industry reduce attrition rates?

De novo sphingolipid synthesis is essential for viability, but not for transport of glycosylphosphatidylinositol-anchored proteins, in African trypanosomes.

Discovery and evaluation of inhibitors of human sphingosine kinase.

Identification of a κ-opioid agonist as a potent and selective lead for drug development against human African trypanosomiasis.

Fingolimod (FTY720): discovery and development of an oral drug to treat multiple sclerosis.

P304

1859-1861

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1128/AAC.02116-15

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Marcel Kaiser

Vicky M. Avery

P577

2015-12-14T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

26666915

http://www.w3.org/2001/XMLSchema#string

P921

African trypanosomiasis

trypanosomiasis

P932

4775930

http://www.w3.org/2001/XMLSchema#string

Identification and Characterization of FTY720 for the Treatment of Human African Trypanosomiasis.

about

P2860

P2860

Identification and Characterization of FTY720 for the Treatment of Human African Trypanosomiasis.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P407

P433

P478

P50

P577

P698

P921

P932

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P407

P433

P478

P50

P577

P698

P921

P932